BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Z, Zhu L, Roberts R, Tong W. Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We? Trends Genet 2019;35:852-67. [PMID: 31623871 DOI: 10.1016/j.tig.2019.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Wadowska K, Bil-Lula I, Trembecki Ł, Śliwińska-Mossoń M. Genetic Markers in Lung Cancer Diagnosis: A Review. Int J Mol Sci 2020;21:E4569. [PMID: 32604993 DOI: 10.3390/ijms21134569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
2 Sicking M, Živná M, Bhadra P, Barešová V, Tirincsi A, Hadzibeganovic D, Hodaňová K, Vyleťal P, Sovová J, Jedličková I, Jung M, Bell T, Helms V, Bleyer AJ, Kmoch S, Cavalié A, Lang S. Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin. Life Sci Alliance 2022;5:e202101150. [PMID: 35064074 DOI: 10.26508/lsa.202101150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Goetz KE, Reeves MJ, Gagadam S, Blain D, Bender C, Lwin C, Naik A, Tumminia SJ, Hufnagel RB. Genetic testing for inherited eye conditions in over 6,000 individuals through the eyeGENE network. Am J Med Genet C Semin Med Genet 2020;184:828-37. [PMID: 32893963 DOI: 10.1002/ajmg.c.31843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Guo M, Li S, Zhou Y, Li M, Wen Z. Comparative Analysis for the Performance of Long-Read-Based Structural Variation Detection Pipelines in Tandem Repeat Regions. Front Pharmacol 2021;12:658072. [PMID: 34163355 DOI: 10.3389/fphar.2021.658072] [Reference Citation Analysis]
5 Wu Y, Liao L, Lin F. The diagnostic protocol for hereditary spherocytosis-2021 update. J Clin Lab Anal 2021;:e24034. [PMID: 34689357 DOI: 10.1002/jcla.24034] [Reference Citation Analysis]
6 Li R, Wang J, Wang L, Lu Y, Wang C. Two novel mutations of COL1A1 in fetal genetic skeletal dysplasia of Chinese. Mol Genet Genomic Med 2020;8:e1105. [PMID: 31898422 DOI: 10.1002/mgg3.1105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Sun H, Shen XR, Fang ZB, Jiang ZZ, Wei XJ, Wang ZY, Yu XF. Next-Generation Sequencing Technologies and Neurogenetic Diseases. Life (Basel) 2021;11:361. [PMID: 33921670 DOI: 10.3390/life11040361] [Reference Citation Analysis]
8 Ding X, Schimenti JC. Strategies to Identify Genetic Variants Causing Infertility. Trends Mol Med 2021;27:792-806. [PMID: 33431240 DOI: 10.1016/j.molmed.2020.12.008] [Reference Citation Analysis]
9 Liu Z, Hatim Q, Thakkar S, Roberts R, Shi T. Editorial: Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Theraphy Development. Front Pharmacol 2022;13:877401. [PMID: 35479329 DOI: 10.3389/fphar.2022.877401] [Reference Citation Analysis]
10 Kolemen AB, Akyuz E, Toprak A, Deveci E, Yesil G. Evaluation of the parents' anxiety levels before and after the diagnosis of their child with a rare genetic disease: the necessity of psychological support. Orphanet J Rare Dis 2021;16:402. [PMID: 34583726 DOI: 10.1186/s13023-021-02046-2] [Reference Citation Analysis]
11 Kerr K, Mckenna C, Heggarty S, Bailie C, Mcmullan J, Crowe A, Kilner J, Donnelly M, Boyle S, Rea G, Flanagan C, Mckee S, Mcknight AJ. A Formative Study of the Implementation of Whole Genome Sequencing in Northern Ireland. Genes 2022;13:1104. [DOI: 10.3390/genes13071104] [Reference Citation Analysis]
12 Rijckmans E, Stouffs K, Jansen AC, Brock S. Malformations of cerebral development and clues from the peripheral nervous system: A systematic literature review. Eur J Paediatr Neurol 2021:S1090-3798(21)00156-2. [PMID: 34535379 DOI: 10.1016/j.ejpn.2021.08.006] [Reference Citation Analysis]
13 Liu Z, Roberts R, Shi T, Mikailov M, Tong W. Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development. Front Pharmacol 2020;11:598889. [PMID: 33101045 DOI: 10.3389/fphar.2020.598889] [Reference Citation Analysis]
14 Boegel S, Castle JC, Schwarting A. Current status of use of high throughput nucleotide sequencing in rheumatology. RMD Open 2021;7:e001324. [PMID: 33408124 DOI: 10.1136/rmdopen-2020-001324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cheng N, Fu J, Chen D, Chen S, Wang H. An antibody-free liver cancer screening approach based on nanoplasmonics biosensing chips via spectrum-based deep learning. NanoImpact 2021;21:100296. [DOI: 10.1016/j.impact.2021.100296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Horgan D, Curigliano G, Rieß O, Hofman P, Büttner R, Conte P, Cufer T, Gallagher WM, Georges N, Kerr K, Penault-Llorca F, Mastris K, Pinto C, Van Meerbeeck J, Munzone E, Thomas M, Ujupan S, Vainer GW, Velthaus JL, André F. Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe. J Pers Med 2022;12:72. [PMID: 35055387 DOI: 10.3390/jpm12010072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
17 Cheng X, Wu D, Cheng Y, Qiao T, Wang X. New focuses of clinical and translational medicine in 2020. Clin Transl Med 2020;10:17-9. [PMID: 32508045 DOI: 10.1002/ctm2.9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Bernier A, Taylor IE. Rare disease data stewardship in Canada. FACETS 2020;5:836-63. [DOI: 10.1139/facets-2020-0050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhou X, Zhong X, Duan L. Integration of Artificial Intelligence And Multi-omics in Kidney Diseases. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.01.037] [Reference Citation Analysis]
20 Stefanski A, Pérez-Palma E, Mrdjen M, McHugh M, Leu C, Lal D. Identification and quantification of oligogenic loss-of-function disorders. Genet Med 2021:S1098-3600(21)05381-8. [PMID: 34906500 DOI: 10.1016/j.gim.2021.10.026] [Reference Citation Analysis]
21 Li B, Wang Z, Chen Q, Li K, Wang X, Wang Y, Zeng Q, Han Y, Lu B, Zhao Y, Zhang R, Jiang L, Pan H, Luo T, Zhang Y, Fang Z, Xiao X, Zhou X, Wang R, Zhou L, Wang Y, Yuan Z, Xia L, Guo J, Tang B, Xia K, Zhao G, Li J. GPCards: An integrated database of genotype-phenotype correlations in human genetic diseases. Comput Struct Biotechnol J 2021;19:1603-11. [PMID: 33868597 DOI: 10.1016/j.csbj.2021.03.011] [Reference Citation Analysis]
22 Fioretti T, Auricchio L, Piccirillo A, Vitiello G, Ambrosio A, Cattaneo F, Ammendola R, Esposito G. Multi-Gene Next-Generation Sequencing for Molecular Diagnosis of Autosomal Recessive Congenital Ichthyosis: A Genotype-Phenotype Study of Four Italian Patients. Diagnostics (Basel) 2020;10:E995. [PMID: 33255364 DOI: 10.3390/diagnostics10120995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Liu Z, Roberts RA, Lal-Nag M, Chen X, Huang R, Tong W. AI-based language models powering drug discovery and development. Drug Discov Today 2021:S1359-6446(21)00281-6. [PMID: 34216835 DOI: 10.1016/j.drudis.2021.06.009] [Reference Citation Analysis]
24 Liu Z, Chen X, Roberts R, Huang R, Mikailov M, Tong W. Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma. Front Pharmacol 2021;12:608778. [PMID: 33967751 DOI: 10.3389/fphar.2021.608778] [Reference Citation Analysis]
25 Schuler BA, Nelson ET, Koziura M, Cogan JD, Hamid R, Phillips JA 3rd. Lessons learned: next-generation sequencing applied to undiagnosed genetic diseases. J Clin Invest 2022;132:e154942. [PMID: 35362483 DOI: 10.1172/JCI154942] [Reference Citation Analysis]
26 Kruse J, Mueller R, Aghdassi AA, Lerch MM, Salloch S. Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects. Front Genet 2021;12:701988. [PMID: 35154238 DOI: 10.3389/fgene.2021.701988] [Reference Citation Analysis]
27 Yubero D, Natera-de Benito D, Pijuan J, Armstrong J, Martorell L, Fernàndez G, Maynou J, Jou C, Roldan M, Ortez C, Nascimento A, Hoenicka J, Palau F. The Increasing Impact of Translational Research in the Molecular Diagnostics of Neuromuscular Diseases. Int J Mol Sci 2021;22:4274. [PMID: 33924139 DOI: 10.3390/ijms22084274] [Reference Citation Analysis]
28 Uhlig HH, Charbit-Henrion F, Kotlarz D, Shouval DS, Schwerd T, Strisciuglio C, de Ridder L, van Limbergen J, Macchi M, Snapper SB, Ruemmele FM, Wilson DC, Travis SPL, Griffiths AM, Turner D, Klein C, Muise AM, Russell RK; Paediatric IBD Porto group of ESPGHAN. Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2021;72:456-73. [PMID: 33346580 DOI: 10.1097/MPG.0000000000003017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
29 Martinez-Granero F, Blanco-Kelly F, Sanchez-Jimeno C, Avila-Fernandez A, Arteche A, Bustamante-Aragones A, Rodilla C, Rodríguez-Pinilla E, Riveiro-Alvarez R, Tahsin-Swafiri S, Trujillo-Tiebas MJ, Ayuso C, Rodríguez de Alba M, Lorda-Sanchez I, Almoguera B. Comparison of the diagnostic yield of aCGH and genome-wide sequencing across different neurodevelopmental disorders. NPJ Genom Med 2021;6:25. [PMID: 33767182 DOI: 10.1038/s41525-021-00188-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Caron NR, Chongo M, Hudson M, Arbour L, Wasserman WW, Robertson S, Correard S, Wilcox P. Indigenous Genomic Databases: Pragmatic Considerations and Cultural Contexts. Front Public Health 2020;8:111. [PMID: 32391301 DOI: 10.3389/fpubh.2020.00111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]